Citicoline Dose on Energy Drink Efficacy

March 20, 2025 updated by: Nathaniel Jenkins

The Effect of Citicoline and Caffeine Dose in a Commercial Energy Drink on Cognitive Performance, Energy Expenditure and Fat Oxidation in Young Adults

The purpose of this study is to determine how the doses of cognitive-enhancing ingredients such as citicoline and caffeine effect the efficacy of acute energy drink consumption for improving cognitive performance (primary outcome), gaming performance, mood, energy expenditure, and fat oxidation. This study will utilize an In vivo acute response, randomized, double-blind, placebo controlled, cross-over trial study design. Participants will complete consent, complete screening, and then undergo familiarization and complete four experimental study visits. In brief, participants will consume a commercially available energy drink specifically formulated to improve cognitive performance with the standard dose of Cognizin, a reduced dose of Cognizin, a reduced dose of caffeine and Cognizin, or a placebo (water, which will be carbonated, matched for flavor, mouthfeel, etc.), then complete a battery of computer-based cognitive performance test, tasks in a video game (Tetris) to assess video game performance, have their resting metabolism analyzed, and then assessments of mood. Following a 1-week washout period, participants will return and consume one of the four remaining beverages and complete the same tasks. They will participate in four experimental visits, each time consuming a different beverage until they have consumed all beverages and completed all necessary tasks.

Question(s) and Hypotheses (stated in null) Q: Does acute consumption of a new formulations (reduced active ingredients [citicoline and caffeine]) of a commercially available energy drink elicit similar improvements in cognitive performance, mood, energy expenditure and fat oxidation in young adults than the standard, currently marketed dose to formulation?

H1: Acute consumption of the commercially available energy drink with standard dosing will improve cognitive performance compared to the reduced dose beverages and the placebo.

H2: Acute consumption of the commercially available energy drink with standard dosing will improve gaming (Tetris) performance compared to the reduced dose beverages and the placebo.

H3: Acute consumption of the commercially available energy drink with standard dosing will improve mood compared to the reduced dose beverages and the placebo.

H4: Acute consumption of a commercially available energy drink with standard dosing will increase energy expenditure and fat oxidation compared to the reduced dose beverages and the placebo.

Study Overview

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Fitness: Healthy, recreationally trained (>2 d/wk physical activity)
  • BMI: (<30kg/m2) or BF <25% (M) and <32% (F)

Exclusion Criteria:

  • <1 hr/wk playing video games
  • >=21 servings of >=170.5 mL (or >=6 fl oz) caffeine beverages per week [(PMID: 33525438)]
  • Injury or illness
  • Habitual nicotine or cannabis use
  • Use of prescription ADD/ADHD, anti-depressant, or other central acting medication, or previously diagnosed ADD/ADHD, clinical depression, or other mental health condition
  • Use of prescription, OTC, or dietary supplements to support sleep, or having been diagnosed with a clinical sleep condition
  • Current or prior chronic (>6 mo) illicit drug or alcohol abuse
  • Clinically diagnosed with, or taking medication for a cardiometabolic disease or disorder (e.g., Pre-diabetes, Type II diabetes, high blood pressure, chronic kidney disease, cardiovascular disease, obesity, etc.)
  • Clinically diagnosed digestive disorder or sensitivity, or regular use of OTC or dietary supplements to support gastrointestinal pain or discomfort
  • Competitive athlete
  • Failure to comply with the controls and conditions of this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Energy Drink
C4 Smart Energy, 1 can, administered acutely
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
Experimental: Reduced Citicoline Energy Drink
C4 Smart Energy Reduced Citicoline, 1 can, administered acutely
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
Experimental: Reduced Citicoline and Caffeine Energy Drink
C4 Smart Energy Reduced Citicoline and Caffeine, 1 can, administered acutely
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.
Placebo Comparator: Placebo
Placebo Drink devoid of active ingredients, 1 can, administered acutely
Participants will consume an energy drink (or placebo) and then undergo experimental testing after a 40 minute rest period following drink consumption.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Executive Function
Time Frame: 60 minutes post-drink consumption
How well a subject recognizes rules, categories, and manages or navigates rapid decision making. Assessed as Shifting Attention Task (SAT) Correct Responses - SAT Errors.
60 minutes post-drink consumption
Resting Fat Oxidation
Time Frame: 50 minutes post-drink consumption
Resting fat oxidation (g/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
50 minutes post-drink consumption
Video Game Performance
Time Frame: 90 minutes post-drink consumption
Performance in the two-dimensional visuospatial game Tetris. Participants will be given four minutes of play time on Marathon mode and instructed to maximize the score (points) displayed on the screen. The total score at the end of play time will be recorded.
90 minutes post-drink consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained Attention
Time Frame: 60 minutes post-drink consumption

Measure of how well a subject can direct and focus cognitive activity on specific stimuli. Assessed using the 4-part Continuous Performance Test, which requires the subject to respond to the target stimulus "B" but not to any other letter. Stimuli are presented at random and the subject responds by pressing the SPACE BAR. Sustained Attention is then quantified as:

(Part 2 Correct Responses + Part 3 Correct Responses + Part 4 Correct Responses) - (Part 2 Incorrect Responses + Part 3 Incorrect Responses + Part 4 Incorrect Responses)

60 minutes post-drink consumption
Psychomotor Speed
Time Frame: 60 minutes post-drink consumption

Measure of how well a subject perceives, attends, responds to visual-perceptual information, and performs motor speed and fine motor coordination. To assess psychomotor speed, participants will complete two tests:

  1. The finger tapping test (FTT), which requires subjects respond by pressing the SPACE BAR with their right index finger as many times as they can in 10 seconds. They do this once for practice, and then there are three test trials. The test is repeated with the left hand; and
  2. The symbol digit coding test (SDC), which consists of serial presentations of screens, each of which contains a bank of eight symbols above eight empty boxes. The participant types in the number on the NUMBER ROW that corresponds to the symbol that is highlighted.

Psychomotor Speed is then quantified as a singular outcome using data aggregated from these two tests as:

FTT Right Taps Average + FTT Left Taps Average + SDC Correct Responses

60 minutes post-drink consumption
Working Memory
Time Frame: 60 minutes post-drink consumption

Measure of how well a subject can perceive and attend to symbols using short-term memory processes. Working memory is assessed via completion of the 4-part Continuous Performance Test, which requires the subject to respond to the target stimulus "B" but not to any other letter. Stimuli are presented at random and the subject responds by pressing the SPACE BAR.

Working memory is assessed as: Part 4 Correct Responses - Part 4 Incorrect Responses

60 minutes post-drink consumption
Cognitive Flexibility
Time Frame: 60 minutes post-drink consumption

Measure of how well subject is able to adapt to rapidly changing and increasingly complex set of directions and/or to manipulate the information. Two tests will be used to assess:

  1. the Shifting Attention Test (SAT), where a square or circle appears at the top of the screen and a square and a circle on the bottom. The figures are either red or blue. The participant is asked to match a bottom figure to the top figure by shape or color with the rules changing at random; and
  2. the Stroop Test, which requires participants to identify the words red, yellow, blue, and green appearing on the screen (part 1), when the color of the word matches what the word says (part 2), or when the color of the word does not match what the word says (part 3).

Cognitive Flexibility is then quantified as a singular outcome using data aggregated from these two tests as: SAT Correct Responses - SAT Errors - Stroop Commission Errors

60 minutes post-drink consumption
Resting Metabolic Rate
Time Frame: 50 minutes post-drink consumption
Resting metabolic rate (kcal/min) will be quantified from resting, fasted analyses of pulmonary gas exchange.
50 minutes post-drink consumption
Resting Respiratory Exchange Ratio
Time Frame: 50 minutes post-drink consumption
Resting respiratory exchange ratio will be quantified from resting, fasted analyses of pulmonary gas exchange.
50 minutes post-drink consumption
Total Mood Disturbance
Time Frame: 105-minutes post-drink consumption
Total mood disturbance will be quantified using the Profile of Mood State Short Form Questionnaire.
105-minutes post-drink consumption
Vigor-Activity
Time Frame: 105-minutes post-drink consumption
Vigor will be quantified using the Profile of Mood State Short Form
105-minutes post-drink consumption
Heart rate
Time Frame: pre-drink consumption, 40-minutes post-drink consumption, 110 minutes post-drink consumption
Heart rate will be quantified from a standard 3-lead ECG
pre-drink consumption, 40-minutes post-drink consumption, 110 minutes post-drink consumption
Blood Pressure
Time Frame: pre-drink consumption, 40 minutes post-drink consumption, 110 minutes post-drink consumption
Systolic, diastolic, and pulse pressures (mmHg) will be quantified from brachial
pre-drink consumption, 40 minutes post-drink consumption, 110 minutes post-drink consumption

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tension
Time Frame: 105 minutes post-drink consumption
Tension will be quantified using the Profile of Mood State Short Form Questionnaire.
105 minutes post-drink consumption
Fatigue
Time Frame: 105 minutes post-drink consumption
Fatigue will be quantified using the Profile of Mood State Short Form Questionnaire.
105 minutes post-drink consumption
Anger
Time Frame: 105 minutes post-drink consumption
Anger will be quantified using the Profile of Mood State Short Form Questionnaire.
105 minutes post-drink consumption
Confusion
Time Frame: 105 minutes post-drink consumption
Confusion will be quantified using the Profile of Mood State Short Form Questionnaire.
105 minutes post-drink consumption
Friendliness
Time Frame: 105 minutes post-drink consumption
Friendliness will be quantified using the Profile of Mood State Short Form Questionnaire.
105 minutes post-drink consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2023

Primary Completion (Actual)

December 1, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

June 3, 2024

First Submitted That Met QC Criteria

March 20, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 20, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202302574

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Pressure

Clinical Trials on Energy drink consumption

Subscribe